Clozapine Dosing and Monitoring Recommendations

Initial Dosing and Titration

The recommended clozapine dosing should be titrated based on therapeutic response and tolerability, aiming for a plasma level of at least 350 ng/mL, with potential increases up to 550 ng/mL if therapeutic response is not achieved at lower concentrations, as recommended by The Lancet Psychiatry 1
For treatment-resistant schizophrenia, gradually increase the dose based on therapeutic response and tolerability, as recommended by The Lancet Psychiatry 1

Aim for a trough plasma level of at least 350 ng/mL for optimal therapeutic efficacy, as recommended by The Lancet Psychiatry 1
If positive symptoms remain significant at this level, the dose may be increased to produce a plasma concentration of up to 550 ng/mL, as recommended by The Lancet Psychiatry 1

Consider prophylactic lamotrigine if using clozapine concentrations above 550 ng/mL due to increased seizure risk, as recommended by The Lancet Psychiatry 1
The decision to use clozapine concentrations above 550 ng/mL should be made in consultation with patients and carers due to diminishing response rates and increased seizure risk, as recommended by The Lancet Psychiatry 1

Concomitant metformin should be considered when starting clozapine to attenuate potential weight gain, as recommended by The Lancet Psychiatry 1
The number needed to treat to reach a response at clozapine concentrations above 550 ng/mL (compared to 250-550 ng/mL) is 17, as reported by The Lancet Psychiatry 1

For persistent positive symptoms despite adequate clozapine trial, consider augmentation with amisulpride, aripiprazole, or electroconvulsive therapy, as recommended by The Lancet Psychiatry 1
For ongoing negative symptoms, clozapine augmentation with an antidepressant can be considered, as recommended by The Lancet Psychiatry 1